Helius Medical Technologies Inc (HSDT)
1.51
-0.01
(-0.66%)
USD |
NASDAQ |
May 17, 16:00
1.51
0.00 (0.00%)
After-Hours: 20:00
Helius Medical Technologies Enterprise Value: 0.1063M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.1063M |
| May 16, 2024 | 0.2074M |
| May 15, 2024 | 0.3339M |
| May 14, 2024 | 0.3086M |
| May 13, 2024 | 0.6307M |
| May 10, 2024 | 0.4857M |
| May 09, 2024 | 0.6628M |
| May 08, 2024 | -2.048M |
| May 07, 2024 | -2.039M |
| May 06, 2024 | -1.488M |
| May 03, 2024 | -1.09M |
| May 02, 2024 | -1.276M |
| May 01, 2024 | -0.4419M |
| April 30, 2024 | -0.0957M |
| April 29, 2024 | -0.0069M |
| April 26, 2024 | 0.3571M |
| April 25, 2024 | 0.3038M |
| April 24, 2024 | 0.6368M |
| April 23, 2024 | 0.7832M |
| April 22, 2024 | 0.8676M |
| April 19, 2024 | 0.9297M |
| April 18, 2024 | 0.8987M |
| April 17, 2024 | 0.9608M |
| April 16, 2024 | 1.085M |
| April 15, 2024 | 1.529M |
| Date | Value |
|---|---|
| April 12, 2024 | 1.840M |
| April 11, 2024 | 1.689M |
| April 10, 2024 | 1.573M |
| April 09, 2024 | 1.671M |
| April 08, 2024 | 1.786M |
| April 05, 2024 | 1.804M |
| April 04, 2024 | 1.822M |
| April 03, 2024 | 2.115M |
| April 02, 2024 | 1.387M |
| April 01, 2024 | 1.352M |
| March 31, 2024 | 1.538M |
| March 28, 2024 | -0.009M |
| March 27, 2024 | -0.2131M |
| March 26, 2024 | -0.2309M |
| March 25, 2024 | -0.1333M |
| March 22, 2024 | -0.0432M |
| March 21, 2024 | 0.0176M |
| March 20, 2024 | -0.1421M |
| March 19, 2024 | -0.151M |
| March 18, 2024 | -0.0268M |
| March 15, 2024 | -0.1155M |
| March 14, 2024 | -0.3018M |
| March 13, 2024 | -0.009M |
| March 12, 2024 | 0.0753M |
| March 11, 2024 | 0.2128M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-10.59M
Minimum
Dec 27 2022
59.04M
Maximum
Jun 05 2019
11.89M
Average
10.63M
Median
Enterprise Value Benchmarks
| ARCA biopharma Inc | 12.41M |
| Integra Lifesciences Holdings Corp | 1.507B |
| NeuroOne Medical Technologies Corp | 27.28M |
| Perspective Therapeutics Inc | 817.27M |
| Electromed Inc | 130.07M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.516M |
| Revenue (Quarterly) | 0.135M |
| Total Expenses (Quarterly) | 3.551M |
| EPS Diluted (Quarterly) | -3.08 |
| Gross Profit Margin (Quarterly) | 8.89% |
| Profit Margin (Quarterly) | -1.86K% |
| Earnings Yield | -846.6% |
| Normalized Earnings Yield | -1126.76 |